Respiratory

Patients recovering from severe COVID-19 pneumonia may experience persistent lung function impairment long after hospital discharge, with new research highlighting vascular dysfunction as a key driver of long-term damage.

A groundbreaking new study is testing an AI-powered smartphone app designed to help pregnant smokers quit, leveraging social support and adaptive reinforcement learning to improve outcomes.

A recent study explores the potential of school-based rebound therapy to improve chest health, motor function, and quality of life in children with neurodisability and respiratory issues.

A systematic review and meta-analysis has confirmed that positive airway pressure (PAP) therapy significantly reduces the risk of both all-cause and cardiovascular mortality in patients with obstructive sleep apnea (OSA).

A new systematic review highlights a significant but often overlooked complication in tuberculosis (TB) survivors—chronic pulmonary aspergillosis (CPA), a progressive fungal disease that can severely impact respiratory health.

Shared decision-making is widely recommended to improve patient-reported outcomes for those considering lung cancer screening (LCS), yet new research suggests communication may not significantly impact feelings of regret or distress.

A new randomized controlled trial has found that combining transcranial direct current stimulation (tDCS) with aerobic exercise (AE) significantly reduces cigarette cravings and consumption in chronic smokers.

A 12-month interim analysis of the AGILE Phase III open-label extension study confirms that twice-yearly depemokimab, an ultra-long-acting anti-IL-5 biologic, maintains a favorable safety and efficacy profile in patients with type 2 asthma.